These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Programmed death 1 and its ligands do not limit experimental foreign antigen-induced immune complex glomerulonephritis. Ooi JD; Li M; Kourkoutzelos K; Yagita H; Azuma M; Holdsworth SR; Kitching AR Nephrology (Carlton); 2015 Dec; 20(12):892-8. PubMed ID: 26043977 [TBL] [Abstract][Full Text] [Related]
4. Expression of programmed death 1 ligands by murine T cells and APC. Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930 [TBL] [Abstract][Full Text] [Related]
5. The PD-1/PD-Ls pathway and autoimmune diseases. Dai S; Jia R; Zhang X; Fang Q; Huang L Cell Immunol; 2014 Jul; 290(1):72-9. PubMed ID: 24908630 [TBL] [Abstract][Full Text] [Related]
8. Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice. Yadav D; Hill N; Yagita H; Azuma M; Sarvetnick N Cell Immunol; 2009; 258(2):161-71. PubMed ID: 19497561 [TBL] [Abstract][Full Text] [Related]
9. B7-H1 and B7-DC receptors of oral squamous carcinoma cells are upregulated by Porphyromonas gingivalis. Groeger S; Domann E; Gonzales JR; Chakraborty T; Meyle J Immunobiology; 2011 Dec; 216(12):1302-10. PubMed ID: 21723642 [TBL] [Abstract][Full Text] [Related]
10. Differential binding properties of B7-H1 and B7-DC to programmed death-1. Youngnak P; Kozono Y; Kozono H; Iwai H; Otsuki N; Jin H; Omura K; Yagita H; Pardoll DM; Chen L; Azuma M Biochem Biophys Res Commun; 2003 Aug; 307(3):672-7. PubMed ID: 12893276 [TBL] [Abstract][Full Text] [Related]
11. Blockade of B7-H1 (programmed death ligand 1) enhances humoral immunity by positively regulating the generation of T follicular helper cells. Hams E; McCarron MJ; Amu S; Yagita H; Azuma M; Chen L; Fallon PG J Immunol; 2011 May; 186(10):5648-55. PubMed ID: 21490158 [TBL] [Abstract][Full Text] [Related]
12. Role of the Programmed Death-1 (PD-1) pathway in regulation of Theiler's murine encephalomyelitis virus-induced demyelinating disease. Takizawa S; Kaneyama T; Tsugane S; Takeichi N; Yanagisawa S; Ichikawa M; Yagita H; Kim BS; Koh CS J Neuroimmunol; 2014 Sep; 274(1-2):78-85. PubMed ID: 25027060 [TBL] [Abstract][Full Text] [Related]
13. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. Wang S; Bajorath J; Flies DB; Dong H; Honjo T; Chen L J Exp Med; 2003 May; 197(9):1083-91. PubMed ID: 12719480 [TBL] [Abstract][Full Text] [Related]
14. B7-DC (PD-L2) costimulation of CD4 Nie X; Chen W; Zhu Y; Huang B; Yu W; Wu Z; Guo S; Zhu Y; Luo L; Wang S; Chen L Cell Mol Immunol; 2018 Oct; 15(10):888-897. PubMed ID: 28479601 [TBL] [Abstract][Full Text] [Related]
15. Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor. Shin T; Kennedy G; Gorski K; Tsuchiya H; Koseki H; Azuma M; Yagita H; Chen L; Powell J; Pardoll D; Housseau F J Exp Med; 2003 Jul; 198(1):31-8. PubMed ID: 12847135 [TBL] [Abstract][Full Text] [Related]
16. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. Kuipers H; Muskens F; Willart M; Hijdra D; van Assema FB; Coyle AJ; Hoogsteden HC; Lambrecht BN Eur J Immunol; 2006 Sep; 36(9):2472-82. PubMed ID: 16917960 [TBL] [Abstract][Full Text] [Related]
17. The role of programmed cell death-1 (PD-1) and its ligands in pediatric cancer. van Dam LS; de Zwart VM; Meyer-Wentrup FA Pediatr Blood Cancer; 2015 Feb; 62(2):190-197. PubMed ID: 25327979 [TBL] [Abstract][Full Text] [Related]
18. Human decidual macrophages suppress IFN-γ production by T cells through costimulatory B7-H1:PD-1 signaling in early pregnancy. Sayama S; Nagamatsu T; Schust DJ; Itaoka N; Ichikawa M; Kawana K; Yamashita T; Kozuma S; Fujii T J Reprod Immunol; 2013 Dec; 100(2):109-17. PubMed ID: 24045115 [TBL] [Abstract][Full Text] [Related]
19. A fully human monoclonal antibody targeting PD-L1 with potent anti-tumor activity. Luan Y; Chai D; Peng J; Ma S; Wang M; Ma H; Li X; Fu S; Pan X; Wang X; Qin S; Xu T Int Immunopharmacol; 2016 Feb; 31():248-56. PubMed ID: 26773772 [TBL] [Abstract][Full Text] [Related]
20. PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication. Wang XF; Lei Y; Chen M; Chen CB; Ren H; Shi TD J Viral Hepat; 2013 Apr; 20 Suppl 1():27-39. PubMed ID: 23458522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]